Nuclear factor-κB-dependent epithelial to mesenchymal transition induced by HIF-1α activation in pancreatic cancer cells under hypoxic conditions

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Cheng, Zhuo Xin ^a   Sun, Bei ^a   Wang, Shuang Jia ^a   Gao, Yue ^b   Zhang, Ying Mei ^a   Zhou, Hao Xin ^a   Jia, Guang ^a   Wang, Yong Wei ^a   Kong, Rui ^a   Pan, Shang Ha ^a   Xue, Dong Bo ^a   Jiang, Hong Chi ^a   Bai, Xue Wei ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NERVE CELL ADHESION MOLECULE; UVOMORULIN; CADHERIN;

ARTICLE; CANCER CELL; CELL HYPOXIA; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PANCREAS CANCER; PHENOTYPE; PROTEIN EXPRESSION; ANOXIA; GENE EXPRESSION; GENETICS; METABOLISM; PANCREAS TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL CULTURE; TUMOR CELL LINE;

ANOXIA; CADHERINS; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NF-KAPPA B; PANCREATIC NEOPLASMS; PHENOTYPE; TUMOR CELLS, CULTURED;

EID: 80051927592     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023752     Document Type: Article

References (32)

1. Beger HG, Rau B, Gansauge F, Poch B, Link KH, (2003) Treatment of pancreatic cancer: challenge of the facts. World J Surg 27: 1075-1084.
2. Kullmann F, Hollerbach S, Dollinger MM, Harder J, Fuchs M, et al. (2009) Hollerbach, E. Endlicher, Cetuximab plus Gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study. Br J Cancer 100: 1032-1036.
3. Herrmann R, Bodoky G, Ruhstaller T, Glimelius B, Bajetta E, et al. (2007) Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group. J Clin Oncol 25: 2212-2217.
4. Bergman AM, Pinedo HM, Peters GJ, (2002) Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine). Drug Resist Updat 5: 19-33.
5. Harris AL, (2002) Hypoxia: a key regulatory factor in tumor growth. Nature Rev 2: 38-47.
6. Maxwell PH, (2005) The HIF pathway in cancer. Semin Cell Dev Biol 16: 523-530.
7. Semenza GL, (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer pp. 3721-732.
8. Huber MA, Kraut N, Beug H, (2005) Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548-558.
9. Cannito S, Novo E, Compagnone A, Valfrè di Bonzo L, Busletta C, et al. (2008) Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells. Carcinogenesis 29: 2267-2278.
10. Huber MA, Azoitei N, Baumann B, Grünert S, Sommer A, et al. (2004) NF-kappa B is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 114: 569-581.
11. Shin SR, Sánchez-Velar N, Sherr DH, Sonenshein GE, (2006) 7,12-dimethylbenz(a)anthracene treatment of a c-rel mouse mammary tumor cell line induces epithelial to mesenchymal transition via activation of nuclear factor-kappa B. Cancer Res 66: 2570-2575.
12. Chua HL, Bhat-Nakshatri P, Clare SE, Morimiya A, Badve S, et al. (2007) NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of NF-κB and ZEB-2. Oncogene 26: 711-724.
13. Julien S, Puig I, Caretti E, Bonaventure J, Nelles L, et al. (2007) Activation of NF-kappa B by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene 26: 7445-7456.
14. Wang Z, Li Y, Kong D, Banerjee S, Ahmad A, et al. (2009) Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. Cancer Res 69: 2400-2407.
15. Arumugam T, Ramachandran V, Fournier KF, Wang H, Marquis L, et al. (2009) Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res 69: 5820-5828.
16. Fuchs BC, Fujii T, Dorfman JD, Goodwin JM, Zhu AX, et al. (2008) Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells. Cancer Res 68: 2391-2399.
17. Yang AD, Fan F, Camp ER, van Buren G, Liu W, et al. (2006) Chronic oxaliplatin resistance induces epithelial to mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res 12: 4147-4153.
18. Wang W, Abbruzzese JL, Evans DB, Larry L, Cleary KR, et al. (1999) The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res 5: 119-127.
19. Algül H, Adler G, Schmid RM, (2002) NF-kappaB/Rel transcriptional pathway: implications in pancreatic cancer. Int J Gastrointest Cancer 31: 71-78.
20. Chandler NM, Canete JJ, Callery MP, (2004) Increased expression of NF-κB subunits in human pancreatic cancer cells. J Surg Res 118: 9-14.
21. Chandel NS, Trzyna WC, McClintock DS, Schumacker PT, (2000) Role of oxidants in NF-κB activation and TNF-α gene transcription induced by hypoxia and endotoxin. J Immunol 165: 1013-1021.
22. Lluis JM, Buricchi F, Chiarugi P, Morales A, Fernandez-Checa JC, (2007) Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death. Cancer Res 67: 7368-7377.
23. Yokoi K, Fidler IJ, (2004) Hypoxia increases resistance of human pancreatic cancer cells to apoptosis induced by gemcitabine. Clin Cancer Res 10: 2299-2306.
24. Wang SJ, Gao Y, Chen H, Kong R, Jiang HC, et al. (2010) Dihydroartemisinin inactivates NF-kappa B and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo. Cancer Lett 293: 99-108.
25. Kong R, Sun B, Jiang H, Pan S, Chen H, et al. (2010) Downregulation of nuclear factor-kappa B p65 subunit by small interfering RNA synergizes with gemcitabine to inhibit the growth of pancreatic cancer. Cancer Lett 291: 90-98.
26. Min C, Eddy SF, Sherr DH, Sonenshein GE, (2008) NF-κB and epithelial to mesenchymal transition of cancer. J Cell Biochem 104: 733-744.
27. Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, et al. (2008) Direct regulation of TWIST by HIF-1α promotes metastasis. Nat Cell Biol 10: 295-305.
28. Koong AC, Chen EY, Giaccia AJ, (1994) Hypoxia causes the activation of nuclear factor kappaB through the phos-phorylation of IkappaB alpha on tyrosine residues. Cancer Res 54: 1425-1430.
29. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, et al. (2008) NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α. Nature 453: 807-811.
30. Mak Paul, Leav Irwin, Pursell Bryan, et al. (2010) ERb Impedes Prostate Cancer EMT by Destabilizing HIF-1a and Inhibiting VEGF-Mediated Snail Nuclear Localization: Implications for Gleason Grading. Cancer Cell 14: 319-332.
31. Shields MA, Dangi-Garimella S, Krantz SB, Bentrem DJ, Munshi HG, (2011) Pancreatic cancer cells respond to type I collagen by inducing Snail expression to promote membrane type 1-matrix metalloproteinase dependent collagen invasion. J Biol Chem 2 In press.
32. Hotz B, Arndt M, Dullat S, Bhargava S, Buhr HJ, et al. (2007) Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer. Clin Cancer Res 13: 4769-4776.